HIV and Hepatitis.com Coverage of the
41st Annual Meeting of the European Association
for the Study of the Liver (41st EASL)
April 26 - 30, 2006, Vienna, Austria



Liver Tumors (Natural History, Epidemiology,
Diagnosis, and Management)


NATURAL HISTORY OF UNTREATED HEPATOCELLULAR CARCINOMA (HCC) ON CIRRHOSIS: SURVIVAL ANALYSIS AND PROGNOSTIC FACTORS IN 559 PATIENTS  
L Benvegnu. Abstract 242

ANTIOXIDANT SUPPLEMENTS FOR PREVENTION OF LIVER CANCER.
G Bjelakovic. Abstract 243.

EFFECT OF LOW DOSE 5-FLUOROURACIL AND CISPLATIN INTRA-ARTERIAL INFUSION CHEMOTHERAPY IN ADVANCED HEPATOCELLULAR CARCINOMA WITH DECOMPENSATED CIRRHOSIS .
J Y Cheong. Abstract 246.                                                           

RISK FACTORS AND PATTERNS OF EXTRAHEPATIC METASTASIS OF HEPATOCELLULAR CARCINOMA.
W J Chung. Abstract 249.

EFFICACY OF HEPATITIS B VIRUS VACCINATION ON THE REDUCTION OF HEPATOCELLULAR CARCINOM INCIDENCE: POST-NATIONAL PROGRAM SURVEILLANCE.
Y C Chien. Abstract 247.

AGE-DEPENDENT RISK OF HEPATOCELLULAR CARCINOMA BY SEROSTATUS OF HEPATITIS B SURFACE AND E ANTIGENS: A LONG-TERM FOLLOW-UP STUDY ON TWO MILLION PREGNANT WOMEN
C W Fwu. Abstract 252.

THE INCIDENCE OF PRIMARY LIVER CANCER IN DENMARK: A 25-YEAR POPULATION-BASED STUDY.
P Jepsen. Abstract 263.

DETERMINANTS OF HEPATITIS B VIRAL LOAD AND ITS DECLINE OVER TIME: A COMMUNITY-BASED FOLLOW-UP STUDY.  
C J Chen. Abstract 457.

SERUM ALANINE AMINOTRANSFERASE LEVEL, CORRELATED FACTORS, AND RISK OF LIVER DISEASES: A LONG-TERM FOLLOW-UP STUDY.  
C L Jen. Abstract 465.

DIABETES MELLITUS ACCELLERATES THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA (HCC) IN ALCOHOL-RELATED BUT NOT IN VIRUS-RELATED CHRONIC LIVER DISEASE.
 A Vario. Abstract 280.

EFFICACY OF LONG ACTING RELEASE OCTREOTIDE IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: A RANDOMIZED MULTICENTER PHASE III STUDY.
C Verslype. Abstract 281.